The World Health Organisation (WHO) has approved India based manufacturing site in Hyderabad, Biological E Limited, to make Covid vaccines for Jansen/Johnson & Johnson.

“This is a great progress for Quad Vaccine and the US India Health partnership,” said a US Embassy spokesperson.

This manufacturing would be done through US technical support and DFC financing. DFC is a US International Development Finance Corporation that invests in the development and advancing US Foreign Policy.

“Quad partners have collectively committed $524 million to the next phase of CEPI’s (Coalition for Epidemic Preparedness) which is an innovative global partnership working to accelerate the development of vaccines against epidemic and pandemic threats) work, accounting for about 50 per cent of total public investors,” according to the joint statement released by Quad members after the Summit last month.

source/content: newindianexpress.com (headline edited)